Henan company begins production on COVID-19 oral drug
By SHI BAOYIN and ZHENG CAIXIONG |
chinadaily.com.cn |
Updated: 2022-08-03 20:29
Share
Share - WeChat
The production base, which covers an area of 32,000 square meters, will be able to annually produce more than 3 billion tablets in the upcoming years.
Currently the product specification is 1 milligram according to Zhu Guoshan, director of the company's production department.
Space has also been reserved in production workshops and lines for more equipment to further expand production to meet market demands in the future, Zhu said.
Wang Chaoyang, founder of the company, said his company would enhance quality management for medicines produced at his company in the months to come.
